Abstract:Abstract Background Lipopolysaccharide (LPS) is an endotoxin and a vital component of gram-negative bacteria’s outer membrane. During gram-negative bacterial sepsis, LPS regulates osteoclast differentiation and activity, in addition to increasing inflammation. This study aimed to investigate how LPS regulates osteoclast differentiation of RAW 264.7 cells in vitro. Results Herein, we revealed that RAW cells failed to differentiate into mature osteoclasts in vitro in the presence of LPS. However, differentiation occurred in cells primed with receptor activator of nuclear factor-kappa-Β ligand (RANKL) for 24 h and then treated with LPS for 48 h (henceforth, denoted as LPS-treated cells). In cells treated with either RANKL or LPS, an increase in membrane levels of toll-like receptor 4 (TLR4) receptor was observed. Mechanistically, an inhibitor of TLR4 (TAK-242) reduced the number of osteoclasts as well as the secretion of tumor necrosis factor (TNF)-α in LPS-treated cells. RANKL-induced RAW cells secreted a very basal level TNF-α. TAK-242 did not affect RANKL-induced osteoclastogenesis. Increased osteoclast differentiation in LPS-treated osteoclasts was not associated with the RANKL/RANK/OPG axis but connected with the LPS/TLR4/TNF-α tumor necrosis factor receptor (TNFR)-2 axis. We postulate that this is because TAK-242 and a TNF-α antibody suppress osteoclast differentiation. Furthermore, an antibody against TNF-α reduced membrane levels of TNFR-2. Secreted TNF-α appears to function as an autocrine/ paracrine factor in the induction of osteoclastogenesis independent of RANKL. Conclusion TNF-α secreted via LPS/TLR4 signaling regulates osteoclastogenesis in macrophages primed with RANKL and then treated with LPS. Our findings suggest that TLR4/TNF-α might be a potential target to suppress bone loss associated with inflammatory bone diseases, including periodontitis, rheumatoid arthritis, and osteoporosis.

The study of direct differentiation and activation effect of leukotriene B4 on human osteoclast

LTB4 Can Directly Stimulate Human Osteoclast Formation from PBMC Independent of RANKL.

LTB4 Can Stimulate Human Osteoclast Differentiation Dependent of RANKL.

Leukotriene B4 Loaded in Microspheres Inhibits Osteoclast Differentiation and Activation

Differentiation of osteoclast-like cells induced by using different concentrations of M-CSF and RANKL

Stimulation of osteoclast differentiation by lipopolysaccharide

The effect of TGF-β on osteoclast differentiation in vitro

Cellular Study of the LPS-induced Osteoclastic Multinucleated Cell Formation from RAW264.7 Cells.

The Effect of Lycopene on the Differentiation of Osteoclast Induced from Bone Marrow in Mice

Induction of osteoclast-like cells from human peripheral blood mononuclear cells by RANKL and M-CSF in vitro

Effect of Lutein on the Differentiation of Osteoclast Induced From Bone Marrow in Mice

Effects of Recombinant Human Osteoprotegerin and Recombinant RANK Protein on the Differentiation of Osteoclast Precursors

Establishment of two experimental models of osteoclast differentiation induced by cytokines

[Effect of TNF-alpha on Murine Osteoclast Differentiation].

RANKL-independent modulation of osteoclastogenesis

Lipopolysaccharide- TLR-4 Axis regulates Osteoclastogenesis independent of RANKL/RANK signaling

The Effect of 137cs Γ-Rays on the Differentiation of Human Peripheral Blood Mononuclear Cells to Osteoclast-Like Cells

Experimental study of the metal-regulatory transcription factor-1 on osteoclast differentiation and function

Effect of JAK2/STAT3 Signaling Pathway on RANKL-induced Osteoclastogenesis in RAW264.7 Cells

Effect of Trans-resveratrol on the Differentiation of Osteoclast Induced from Bone Marrow in Mice

Effects of osteoblasts on the formation of osteoclasts in vitro